14th Apr 2015 09:35
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R(1)(a) GlaxoSmithKline plc ('GSK') was advised on 13 April 2015, of changes in the interests of the following Directors and Persons Discharging Managerial Responsibility, following increases in their notional interests in Ordinary Shares and American Depositary Shares (ADSs), at a price of 1591.00 pence per Ordinary Share and $47.41 per ADS, following the re-investment of dividends paid on Ordinary Shares and ADSs held in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan.
Director/PDMR |
Number of Ordinary Shares acquired under the personal contribution element of the plan |
Number of Ordinary Shares acquired under the matching element of the plan (GSK contribution) |
Sir Andrew Witty |
1,803 |
1,803 |
Mr S Dingemans |
687 |
687 |
Mr R G Connor |
358 |
358 |
Mr N Hirons |
77 |
77 |
Mr S A Hussain |
307 |
307 |
Mr D S Redfern |
384 |
384 |
Ms C Thomas |
264 |
264 |
Mr P C Thomson |
129 |
129 |
Dr P J T Vallance |
922 |
922 |
Ms E Walmsley |
542 |
542 |
Director/PDMR |
Number of ADSs acquired under the personal contribution element of the plan |
Number of ADSs acquired under the matching element of the plan (GSK contribution) |
Dr M M Slaoui |
713 |
713 |
Mr W C Louv |
183 |
183 |
Mr D E Troy |
301 |
301 |
V A Whyte
Company Secretary
14 April 2015
Related Shares:
Glaxosmithkline